Pharmacogenetics

Wijnen PAHM, Drent M, Nelemans P, et al.
Relationship of cytochrome P450 polymorphisms in pulmonary drug toxicity.
Drug Saf; 2008: 31: 1125-34.

Ansell J, Hirsh J, Hylek E, et al.
Pharmacology and management of the vitamin K antagonists: chest physicians evidence-based clinical practice guidelines (8th edition).
Chest 2008;133: 160-198.

Sconce E, et al.
Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin.
Blood 2007;109: 2419-23.

Bakker JA, Drent M, Bierau J.
Relevance of pharmacogenetic aspects of mercaptopurine metabolism in the treatment of ILD.
Curr Opion Pulm Med 2007; 13: 458-63.

Genelex Corporation
Physician Guidelines: Drugs Metabolized by Cytochrome P450’s
2005

Levien T, Baker D.
Cytochrome P450 Drug Interactions
Therapeutic Research Center Pharmacist’s Letter / Prescriber’s Letter 2003